MedPath

CEFOTAXIME SODIUM FOR INJECTION, BP

CEFOTAXIME SODIUM FOR INJECTION, BP

Approved
DIN Number

02434083

Drug Class

Human

Market Date

N/A

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02434083
AIG Number0152507003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD01 CEFOTAXIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous ,  Intramuscular
AHFS Classification08:12.06.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFOTAXIME SODIUMActive
Strength: 500 MG / VIAL
Monograph: CEFOTAXIME SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.